BioCentury
ARTICLE | Financial News

BT Pharma raises EUR 13.1 million

March 10, 2010 2:10 AM UTC

BT Pharma S.A. (Labege, France) raised EUR 13.1 million ($17.8 million) in a series B round led by new investor AGF. Additional new investors Institut Regional de Developpement Industriel; Amundi Private Equity Funds; and InnoBio fund joined existing investors, including Edmond de Rothschild Investment Partners. InnoBio is a venture fund managed by CDC Entreprises. ...